Loading…
Medicus Pharma Ltd. is projected to decline to $0.3069 by 2027, a -1% move from its current price of $0.3085. MDCX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.2918 | $0.3087 | $0.3266 | +0.07% |
| May 30 | $0.2852 | $0.3089 | $0.3345 | +0.13% |
| May 31 | $0.2804 | $0.3091 | $0.3408 | +0.20% |
| Jun 1 | $0.2763 | $0.3093 | $0.3462 | +0.26% |
| Jun 2 | $0.2729 | $0.3095 | $0.3511 | +0.33% |
| Jun 3 | $0.2698 | $0.3097 | $0.3556 | +0.39% |
| Jun 4 | $0.267 | $0.3099 | $0.3598 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.267 | $0.3099 | $0.3598 | +0.46% |
| Week 2 | $0.2521 | $0.3113 | $0.3845 | +0.92% |
| Week 3 | $0.2416 | $0.3128 | $0.405 | +1.39% |
| Week 4 | $0.2332 | $0.3142 | $0.4234 | +1.85% |
| Week 5 | $0.2262 | $0.3157 | $0.4406 | +2.32% |
| Week 6 | $0.2201 | $0.3171 | $0.457 | +2.79% |
| Week 7 | $0.2147 | $0.3186 | $0.4727 | +3.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome.
The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Medicus Pharma Ltd. (MDCX) is a biotech/life sciences company focused on developing clinical development programs of therapeutic assets in the United States.
The current price is $0.30 and the market capitalization is $17M, with a rank of 5000.
Forecasts indicate a path of upside potential over the long term. The 2026 average price is $0.30 with ROI 0, while the forecast spans up to 2050 with a 2050 average of $1.05 and a max of $2.41, corresponding to ROI 249.8. The sentiment shifts to BULLISH in later years, reflecting a longer horizon upside potential.
These figures are estimates and not guarantees.
A major floor 23.6% below — a decisive break under it would weaken the trend.
The nearest floor, 10.9% below — buyers have tended to step in here.
The nearest ceiling, 13.8% above — a clean break opens room to run.
A major ceiling 395.9% above — clearing it would confirm fresh momentum.
Key MDCX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MDCX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.2954 | Buy | $0.299 | Buy |
| MA 10 | $0.3004 | Buy | $0.3005 | Buy |
| MA 20 | $0.3029 | Buy | $0.3131 | Sell |
| MA 50 | $0.3694 | Sell | $0.4456 | Sell |
| MA 100 | $0.7686 | Sell | $0.7787 | Sell |
| MA 200 | $1.47 | Sell | $1.34 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.86 | Neutral |
| Stoch RSI (14) | 97.52 | Sell |
| CCI (20) | 23.67 | Neutral |
| Williams %R (14) | -47.46 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -7.76 | Sell |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 52.54 | Neutral |
| TRIX (15) | -1.27 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 51.34 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 0.30 | Buy |
| ADX (14) | 23.61 | Sell |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 40, and the 50-day simple moving average is $0.3788 while the 200-day simple moving average is $1.49.
The 30-day range runs from a low of $0.2042 to a high of $0.4408, with near-term support at $0.275 and resistance at $0.403. Annualized volatility stands at 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.275 | $0.3085 | $0.3617 | 0% | Neutral | |
| $0.2209 | $0.3069 | $0.4615 | -1% | Neutral | |
| $0.2561 | $0.3776 | $0.6036 | +22% | Bullish | |
| $0.2679 | $0.4158 | $0.6969 | +35% | Bullish | |
| $0.2939 | $0.4781 | $0.8335 | +55% | Bullish | |
| $0.2482 | $0.4218 | $0.7607 | +37% | Bullish | |
| $0.2218 | $0.393 | $0.7306 | +27% | Bullish | |
| $0.229 | $0.4227 | $0.8073 | +37% | Bullish | |
| $0.1791 | $0.3438 | $0.6731 | +11% | Neutral | |
| $0.2233 | $0.4455 | $0.8922 | +44% | Bullish | |
| $0.2347 | $0.5216 | $1.15 | +69% | Bullish | |
| $0.489 | $1.09 | $2.50 | +252% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.275 | $0.3085 | $0.3676 | +0.00% |
| June 2026 | $0.2748 | $0.3296 | $0.4096 | +6.84% |
| July 2026 | $0.2685 | $0.3275 | $0.4174 | -0.63% |
| August 2026 | $0.2447 | $0.3025 | $0.393 | -7.65% |
| September 2026 | $0.2429 | $0.3035 | $0.4005 | +0.34% |
| October 2026 | $0.2458 | $0.3103 | $0.4153 | +2.25% |
| November 2026 | $0.2232 | $0.2844 | $0.3852 | -8.36% |
| December 2026 | $0.2054 | $0.264 | $0.3617 | -7.17% |
Click any year to see its month-by-month MDCX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MDCX could reach as high as $0.3617, with a base case around $0.3085 and support toward $0.275 — roughly 0% from $0.3085. A consolidation phase looks the most probable path here.
Expect MDCX to range from $0.2209 to $0.4615 through 2027. The $0.3069 average target implies a -1% move from current prices. That is -1% versus the projected 2026 average. Price action looks broadly range-bound.
The MDCX price prediction for 2028 points to an average of $0.3776 (low $0.2561, high $0.6036) — a potential gain of +22% on today's $0.3085. Buyers look set to stay in control over this stretch.
In 2029, MDCX is projected to trade between $0.2679 and $0.6969, averaging $0.4158 — a potential gain of +35% from today's $0.3085. That is up +10% on the projected 2028 average. Momentum favours further upside here.
Medicus Pharma Ltd.'s 2030 outlook centres on $0.4781, within a $0.2939 to $0.8335 range. That is up +15% on the projected 2029 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, MDCX could reach as high as $0.7607, with a base case around $0.4218 and support toward $0.2482 — roughly +37% from $0.3085. Momentum favours further upside here.
Expect MDCX to range from $0.2218 to $0.7306 through 2032. The $0.393 average target implies a +27% move from current prices. That is -7% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
The MDCX price prediction for 2033 points to an average of $0.4227 (low $0.229, high $0.8073) — a potential gain of +37% on today's $0.3085. Momentum favours further upside here.
In 2034, MDCX is projected to trade between $0.1791 and $0.6731, averaging $0.3438 — a potential gain of +11% from today's $0.3085. That is -19% versus the projected 2033 average. A consolidation phase looks the most probable path here.
Medicus Pharma Ltd.'s 2035 outlook centres on $0.4455, within a $0.2233 to $0.8922 range. That is up +30% on the projected 2034 average. That marks a +44% change versus current levels. Momentum favours further upside here.
By 2040, MDCX could reach as high as $1.15, with a base case around $0.5216 and support toward $0.2347 — roughly +69% from $0.3085. Buyers look set to stay in control over this stretch.
Expect MDCX to range from $0.489 to $2.50 through 2050. The $1.09 average target implies a +252% move from current prices. That is up +108% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MDCX today (≈ 3,241.491086 MDCX) could be worth
$3,522.73
+$2,522.73 (+252%) by 2050 · US Dollar
Based on the average projected MDCX price of $1.09 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDCXwould be worth at today's price.
$1,000 invested in MDCX on May 27, 2025 (≈ 162.337666 MDCX) would be worth
$50.08
-$949.92 (-95.0%) today · 0.05× · US Dollar
Based on a MDCX entry price of $6.16 vs. today's $0.3085.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.29 | $1,063.79 | +6.4% |
| 1 month ago | $0.297 | $1,038.72 | +3.9% |
| 3 months ago | $1.36 | $226.84 | -77.3% |
| 6 months ago | $2.2 | $140.23 | -86.0% |
| 1 year ago | $6.16 | $50.08 | -95.0% |
| All time (1.5y) ago | $2.65 | $116.42 | -88.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MDCX forecast.
Our base-case forecast reaches $0.62 around 2050.
Implied market cap at $0.62: $35.13M
The multi-year forecast shows a bullish tilt emerging in the later years. In 2026 the average price is $0.30 with ROI 0 and sentiment NEUTRAL, followed by a 2027 average of $0.2979 with ROI -0.7 and NEUTRAL sentiment. The trajectory improves from 2028 onward, with 2028 avg $0.3579 ROI 19.3 and 2029 avg $0.3995 ROI 33.2 (sentiment BULLISH).
By 2030 the forecast shows an average of $0.4634 with ROI 54.5 and sentiment BULLISH, and by 2031 the avg is $0.4067 with ROI 35.6. The 2032–2033 window remains bullish with 2032 avg $0.3833 ROI 27.8 and 2033 avg $0.4106 ROI 36.9. 2034 shows a modest uptick to avg $0.3247 ROI 8.2, and 2035 returns to a higher level at avg $0.4266 ROI 42.2 with BULLISH sentiment.
The forecast continues to extend into the next decade, with 2040 average $0.4977 ROI 65.9 and 2050 average $1.05 ROI 249.8, both labeled BULLISH. The 2050 max is $2.41, underscoring meaningful upside potential over the long term, albeit with notable year-to-year variability. These are estimates, not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The forecasted 2030 average price is $0.4634 with a max of $0.8083 and a min of $0.2847; ROI 54.5; sentiment BULLISH.
The year-by-year outlook shows a shift to BULLISH from 2029 onward, with 2050 avg $1.05 and ROI 249.8; near-term years 2026–2027 show neutral or negative ROI (0 and -0.7), indicating potential upside but with near-term risk.
Yes. The forecasted 2050 average is $1.05 and the 2050 max is $2.41, indicating the possibility of surpassing $1 over the horizon.
Current sentiment is NEUTRAL. RSI14 is 40, SMA50 is $0.3788, SMA200 is $1.49. The 30-day range is $0.2042–$0.4408 with support at $0.275 and resistance at $0.403.
Current price is $0.30 and market capitalization is $17M; the market rank is 5000.
Medicus Pharma Ltd. Community Discussion
0Share your Medicus Pharma Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.